Addex Therapeutics Ltd. (ADXN) Total Current Liabilities (2022 - 2024)

Addex Therapeutics' Total Current Liabilities history spans 3 years, with the latest figure at $915606.7 for Q4 2024.

  • For Q4 2024, Total Current Liabilities fell 71.93% year-over-year to $915606.7; the TTM value through Dec 2024 reached $915606.7, down 71.93%, while the annual FY2024 figure was $911740.3, 71.7% down from the prior year.
  • Total Current Liabilities for Q4 2024 was $915606.7 at Addex Therapeutics, down from $3.3 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $3.4 million in Q4 2022 and bottomed at $915606.7 in Q4 2024.
  • The 3-year median for Total Current Liabilities is $3.3 million (2023), against an average of $2.5 million.
  • The largest annual shift saw Total Current Liabilities fell 4.26% in 2023 before it crashed 71.93% in 2024.
  • A 3-year view of Total Current Liabilities shows it stood at $3.4 million in 2022, then dropped by 4.26% to $3.3 million in 2023, then plummeted by 71.93% to $915606.7 in 2024.
  • Per Business Quant, the three most recent readings for ADXN's Total Current Liabilities are $915606.7 (Q4 2024), $3.3 million (Q4 2023), and $3.4 million (Q4 2022).